News
FDA Consumer Health Information: Using Malaria Medication For Leg Cramps Is Risky
July 8, 2010 1:37 pm | by Bio-Medicine.Org | CommentsSILVER SPRING, Md. , July 8 /PRNewswire-USNewswire/ -- People who use the malaria drug Qualaquin to treat or prevent nighttime leg cramps may want to talk to their health care professional. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:...
Que She Herbal Supplement: Undeclared Drug Ingredients
July 8, 2010 1:31 pm | by U.S. Food & Drug Administration | CommentsHerbal product, sold as weight loss supplement, contains unlisted active pharmaceutical ingredients. Risk of serious side effects, especially in those with heart conditions.
Conference bursaries make malaria mission possible
July 8, 2010 10:39 am | by EurekAlert | Comments(BioMed Central) Today, BioMed Central announced a fund to help researchers in developing countries attend the conference, Parasite to Prevention. The conference, held in conjunction with Malaria Journal, takes place in Edinburgh UK, Oct. 20-22, 2010.
University of Manchester academics at international conference on geographic chemicals
July 8, 2010 10:39 am | by EurekAlert | Comments(University of Manchester) A major conference, organized by scientists at the University of Manchester to showcase vital work on the effect of geographic chemicals, begins today.
Nanotechnology: nanomaterials are widely used in commerce, but EPA faces challenges in regulating risk
July 8, 2010 10:39 am | by I-Micronews | CommentsNanotechnology involves the ability to control matter at the scale of a nanometer--one billionth of a meter. The world market for products that contain nanomaterials is expected to reach $2.6 trillion by 2015.
The thinnest, smoothest metallic lines in the world helps speed up miniaturisation of electronic devices
July 8, 2010 10:39 am | by I-Micronews | CommentsNew method creates super-thin, high integrity, continuous metal lines that surpass today?s semiconductor industry requirements.
Nichia to start sample shipment of green diode laser
July 8, 2010 10:39 am | by I-Micronews | CommentsNichia Corp will finally commercialize its green diode laser for use mainly in pico projectors.
Genzyme to transfer more manufacturing to Hospira
July 8, 2010 10:38 am | by Mass High Tech: The Journal of New England Technology | CommentsGenzyme Corp. is expanding a deal designed to transfer more so-called fill-finish manufacturing work to Hospira Worldwide Inc. – part of an agreement with the U.S. FDA to comply with an enforcement action against the Cambridge-based biotechnology company.
PEAK Surgical Introduces PEAK PlasmaBlade(R) 3.0S
July 8, 2010 10:37 am | by Bio-Medicine.Org | CommentsPALO ALTO, Calif. , July 8 /- PEAK Surgical, Inc. today announced the launch of the PEAK PlasmaBlade® 3.0S dissection device following 510(k) clearance from the U.S. Food and Drug Administration (FDA). This revolutionary product features a 3.0mm wide blade for even greater cutting...
Unprecedented Donation Made by Mrs. Lily Safra to the Institute for Brain and Spinal Cord Disorders in Paris
July 8, 2010 10:37 am | by Bio-Medicine.Org | CommentsPARIS , July 8, 2010 /- Professor Gerard Saillant , President of the Institute for Brain and Spinal Cord Disorders (ICM), announced today an unprecedented donation of EUR8,000,000 from Mrs. Lily Safra . It is the largest single donation made by a private individual to the ICM. Professor Saillant...
ECRI Institute Adds 4,000 New Terms to Universal Medical Device Nomenclature Systemâ„¢
July 8, 2010 10:35 am | by Bio-Medicine.Org | CommentsFree license gives access to 24,544 terms, including genetic testing and device software PLYMOUTH MEETING, Pa. , July 8 /PRNewswire-USNewswire/ -- ECRI Institute's Universal Medical Device Nomenclature System™, the most comprehensive medical device taxonomy, announces the...
Exagen Diagnostics Receives Lab Accreditation From College of American Pathologists
July 8, 2010 10:35 am | by Bio-Medicine.Org | CommentsALBUQUERQUE, N.M. , July 8 /- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP). The CAP is a leading...
Qualaquin (quinine sulfate): New Risk Evaluation and Mitigation Strategy - Risk of serious hematological reactions
July 8, 2010 10:31 am | by U.S. Food & Drug Administration | CommentsNew Risk Management Plan. Reports of serious side effects in patients using Qualaquin "off-label" for night time leg cramps.
MDT Forum
July 8, 2010 7:38 am | CommentsThe MDT community forum is a great location to discuss new trends, share tips, give opinions, and exchange ideas.
PMA Final Decisions for May 2010
July 8, 2010 7:37 am | by U.S. Food & Drug Administration | CommentsThese are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for January 2010
